tripalmitylglycerol
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2017 (NCT03002168)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- glycero-tripalmitate
- glyceryl tripalmitate
- hexadecanoic acid, 1,2,3-propanetriyl ester
- tripalmitin
- tripalmitin
- tripalmitin
- tripalmitoylglycerol
- tripalmitoyl glycerol
- tripalmitylglycerol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03002168 | N/A | Jan 1, 2017 | Mayo Clinic, SFI Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2017 |
| SFI Research | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1